Date:11/11/2009

3,039,819 Accumulated comprehensive income - foreign currency translation adjustment 5,898,703 5,719,618 Total Stockholders' Equity 85,174,158 69,868,054 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $95,309,006 $75,471,837 CHINA PHARMA HOLDINGS, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited) For the three months For the nine months ended September 30, ended September 30, 2009 2008 2009 2008 Revenue $15,522,953 $12,610,642 $42,116,290 $35,606,490 Cost of revenue 8,979,083 6,494,266 23,724,155 17,730,026 Gross profit 6,543,870 6,116,376 18,392,135 17,876,464 Operating expenses (benefit): Selling expenses 807,231 529,432 2,013,915 1,323,854 General and administrative 521,676 410,287 1,563,330 1,324,452 Bad debt expense (benefit) (2,836,495) 491,781 (2,101,710) 1,571,594 Total operating expenses (benefit) (1,507,588) 1,431,500 1,475,535 4,219,900 Income from operations 8,051,458 4,684,876 16,916,600 13,656,564 Non-operating income (expenses): Interest income 3,956 26,224 25,265 31,259 Interest expense (24,436) (34,629) (103,143) (130,342) Total non-operating income (expense) (20,480) (8,405) (77,878) (99,083) Income before taxes 8,030,978 4,676,471 16,838,722 13,557,481 Income tax expense 867,750 424,993 1,711,703 1,078,163 Net incom
'/>"/>

SOURCE China Pharma Holdings, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9
Related biology technology :

1. China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2009 Results
2. China Medicine Announces Conference Call to Discuss Third Quarter 2009 Results
3. Monsanto Opens First Biotechnology Research Center in China
4. Chinas Research Output More Than Doubled Since 2004, Thomson Reuters Study Reveals
5. China-Biotics, Inc. Appoints New Vice President
6. Blue Dye Test Alternative Installed at Bayer China for Packaging Quality Assurance Process
7. China Biologic Named to Forbes Magazines Fifth Annual List of Asias 200 Best Under a Billion
8. China Medical Technologies to Exhibit its Products at China International Medical Equipment Fair in Chengdu, China
9. China Medical Technologies Announces the SFDA Approval for its SPR System
10. China Integrated Energy, Inc. Announces Preliminary Third Quarter Financial Results and Increases Full Year Guidance
11. China Integrated Energy, Inc. Announces Eight Million Share Public Follow-On Offering